BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33987958)

  • 1. Detecting the epitranscriptome.
    Sarkar A; Gasperi W; Begley U; Nevins S; Huber SM; Dedon PC; Begley TJ
    Wiley Interdiscip Rev RNA; 2021 Nov; 12(6):e1663. PubMed ID: 33987958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitranscriptomic Code and Its Alterations in Human Disease.
    Kadumuri RV; Janga SC
    Trends Mol Med; 2018 Oct; 24(10):886-903. PubMed ID: 30120023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Census and Categorization Method of Epitranscriptomic Marks.
    Mathlin J; Le Pera L; Colombo T
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring epitranscriptomics for crop improvement and environmental stress tolerance.
    Yang X; Patil S; Joshi S; Jamla M; Kumar V
    Plant Physiol Biochem; 2022 Jul; 183():56-71. PubMed ID: 35567875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaping the Bacterial Epitranscriptome-5'-Terminal and Internal RNA Modifications.
    Schauerte M; Pozhydaieva N; Höfer K
    Adv Biol (Weinh); 2021 Aug; 5(8):e2100834. PubMed ID: 34121369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mark of disease: how mRNA modifications shape genetic and acquired pathologies.
    Destefanis E; Avşar G; Groza P; Romitelli A; Torrini S; Pir P; Conticello SG; Aguilo F; Dassi E
    RNA; 2021 Apr; 27(4):367-389. PubMed ID: 33376192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the epitranscriptome by native RNA sequencing.
    Begik O; Mattick JS; Novoa EM
    RNA; 2022 Nov; 28(11):1430-1439. PubMed ID: 36104106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epitranscriptome toolbox.
    Moshitch-Moshkovitz S; Dominissini D; Rechavi G
    Cell; 2022 Mar; 185(5):764-776. PubMed ID: 35245480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitranscriptome sequencing technologies: decoding RNA modifications.
    Li X; Xiong X; Yi C
    Nat Methods; 2016 Dec; 14(1):23-31. PubMed ID: 28032622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis.
    Chatterjee B; Shen CJ; Majumder P
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitranscriptomic Mass Spectrometry.
    Wang H; Shnaider FM; Martin E; Chiu NHL
    Methods Mol Biol; 2024; 2822():335-349. PubMed ID: 38907927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplays of different types of epitranscriptomic mRNA modifications.
    Rengaraj P; Obrdlík A; Vukić D; Varadarajan NM; Keegan LP; Vaňáčová Š; O'Connell MA
    RNA Biol; 2021 Oct; 18(sup1):19-30. PubMed ID: 34424827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA 5-methylcytosine modification and its emerging role as an epitranscriptomic mark.
    Gao Y; Fang J
    RNA Biol; 2021 Oct; 18(sup1):117-127. PubMed ID: 34288807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of post-transcriptional modifications during development.
    Hamar R; Varga M
    Biol Futur; 2023 Jun; 74(1-2):45-59. PubMed ID: 36481986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of epitranscriptomic marks on post-transcriptional regulation in plants.
    Yu X; Sharma B; Gregory BD
    Brief Funct Genomics; 2021 Mar; 20(2):113-124. PubMed ID: 33274735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitranscriptomic systems regulate the translation of reactive oxygen species detoxifying and disease linked selenoproteins.
    Leonardi A; Evke S; Lee M; Melendez JA; Begley TJ
    Free Radic Biol Med; 2019 Nov; 143():573-593. PubMed ID: 31476365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection techniques for epitranscriptomic marks.
    Ofusa K; Chijimatsu R; Ishii H
    Am J Physiol Cell Physiol; 2022 Apr; 322(4):C787-C793. PubMed ID: 35294846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitranscriptomics in metabolic disease.
    Matsumura Y; Wei FY; Sakai J
    Nat Metab; 2023 Mar; 5(3):370-384. PubMed ID: 36959512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA modifications and cancer.
    Haruehanroengra P; Zheng YY; Zhou Y; Huang Y; Sheng J
    RNA Biol; 2020 Nov; 17(11):1560-1575. PubMed ID: 31994439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.